Our group offers an exceptional environment for clinically grounded medical AI research.
- We maintain the world's largest international research cohort of prostate MRI examinations, comprising more than 22,000 examinations from 46 cities across 22 countries. This cohort has been established in collaboration with a growing scientific consortium of academic and community hospitals, researchers, and clinicians.
- Our previous research includes landmark studies in prostate AI (PI-CAI) and pancreas AI (PANORAMA), published in The Lancet Oncology. These studies focused on developing and rigorously benchmarking state-of-the-art AI systems against more than 60 international radiologists from 45 centres across 20 countries.
-
PROMETHEUS brings together six leading European institutions with complementary expertise in medical imaging, prostate cancer management, longitudinal modelling, and medical AI.
You will be embedded within the Minimally Invasive Image-Guided Intervention Center (MAGIC) and the Diagnostic Image Analysis Group (DIAG) at Radboud University Medical Center in Nijmegen.
MAGIC develops and translates image-guided technologies for minimally invasive cancer diagnosis and treatment into clinical practice and is internationally recognised for its expertise in prostate imaging and intervention.
DIAG is a world-renowned medical AI research group comprising more than 70 researchers. The group combines expertise in radiology, pathology, computer science, and biomedical engineering. Its work spans methodological AI research, large-scale clinical validation, and the translation of AI innovations into medical imaging systems used in clinical practice.
Learn here what it's like to do a PhD at Radboudumc
